Akihiko Miyanaga

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 23

Top Topics

Brain Metastases

Tyrosine Kinase

Epidermal Growth Factor Receptor

Top Venues

OncoTargets and therapy

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Naomi Onda, Shinji Nakamichi, Mariko Hirao, Kuniko Matsuda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression. Cancer science 115 (8) (2024)
Naomi Onda, Shinji Nakamichi, Mariko Hirao, Kuniko Matsuda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression. Cancer science 115 (8) (2024)
Yasuhiro Kato, Masaru Matsumoto, Natsuki Takano, Mariko Hirao, Kuniko Matsuda, Takehiro Tozuka, Naomi Onda, Shinji Nakamichi, Susumu Takeuchi, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway. Cancer medicine 13 (12) (2024)
Joshua K Stone, Natalia von Muhlinen, Chenran Zhang, Ana I Robles, Amy L Flis, Eleazar Vega-Valle, Akihiko Miyanaga, Masaru Matsumoto, K Leigh Greathouse, Tomer Cooks, Giorgio Trinchieri, Curtis C Harris
Acidovorax temperans skews neutrophil maturation and polarizes Th17 cells to promote lung adenocarcinoma development. Oncogenesis 13 (1) (2024)
Joshua K Stone, Natalia von Muhlinen, Chenran Zhang, Ana I Robles, Amy L Flis, Eleazar Vega-Valle, Akihiko Miyanaga, Masaru Matsumoto, K Leigh Greathouse, Tomer Cooks, Giorgio Trinchieri, Curtis C Harris
Acidovorax temperans skews neutrophil maturation and polarizes Th17 cells to promote lung adenocarcinoma development. Oncogenesis 13 (1) (2024)
Yasuhiro Kato, Masaru Matsumoto, Natsuki Takano, Mariko Hirao, Kuniko Matsuda, Takehiro Tozuka, Naomi Onda, Shinji Nakamichi, Susumu Takeuchi, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway. Cancer medicine 13 (12) (2024)
Joshua K Stone, Natalia von Muhlinen, Chenran Zhang, Ana I Robles, Amy L Flis, Eleazar Vega-Valle, Akihiko Miyanaga, Masaru Matsumoto, K Leigh Greathouse, Tomer Cooks, Giorgio Trinchieri, Curtis C Harris
Acidovorax temperans skews neutrophil maturation and polarizes Th17 cells to promote lung adenocarcinoma development. Oncogenesis 13 (1) (2024)
Naomi Onda, Shinji Nakamichi, Mariko Hirao, Kuniko Matsuda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression. Cancer science (2024)
Naomi Onda, Shinji Nakamichi, Mariko Hirao, Kuniko Matsuda, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Afatinib plus PEM and CBDCA overcome osimertinib resistance in EGFR-mutated NSCLC with high thrombospondin-1 expression. Cancer science 115 (8) (2024)
Yasuhiro Kato, Masaru Matsumoto, Natsuki Takano, Mariko Hirao, Kuniko Matsuda, Takehiro Tozuka, Naomi Onda, Shinji Nakamichi, Susumu Takeuchi, Akihiko Miyanaga, Rintaro Noro, Akihiko Gemma, Masahiro Seike
Induction of resistance to neurotrophic tropomyosin-receptor kinase inhibitors by HMGCS2 via a mevalonate pathway. Cancer medicine 13 (12) (2024)
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike
Remarkable Clinical Response of ALK -Rearranged/ TP53 -Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and therapy 16 (2023)
Kazuhito Misawa, Shinji Nakamichi, Hiroki Iida, Atsuhiro Nagano, Erika Mikami, Takehiro Tozuka, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Kaoru Kubota, Hiroki Yamaguchi, Masahiro Seike
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report. OncoTargets and therapy 16 (2023)
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike
Remarkable Clinical Response of ALK -Rearranged/ TP53 -Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and therapy 16 (2023)
Kazutaka Fujita, Ryo Arai, Satoshi Shoji, Ryota Saito, Motoko Nomura, Takamasa Hotta, Hajime Asahina, Masanori Kawakami, Ichiro Nakachi, Yukihiro Hasegawa, Kohei Okafuji, Aya Suzuki, Akihiko Miyanaga, Noriaki Sunaga, Hiromi Nagashima, Naoya Ikeda, Satoshi Watanabe, Yoshiaki Nagai, Megumi Furuta, Hidenori Kage, Daisuke Arai, Tatsuro Fukuhara, Masayuki Nakayama, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine A trial. Cancer science (2023)
Takehiro Tozuka, Rintaro Noro, Akihiko Miyanaga, Shinji Nakamichi, Susumu Takeuchi, Masaru Matsumoto, Kaoru Kubota, Kazuo Kasahara, Masahiro Seike
Osimertinib early dose reduction as a risk to brain metastasis control in EGFR-mutant non-small cell lung cancer. Cancer medicine (2023)
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike
Remarkable Clinical Response of ALK -Rearranged/ TP53 -Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and therapy 16 (2023)
Kazutaka Fujita, Ryo Arai, Satoshi Shoji, Ryota Saito, Motoko Nomura, Takamasa Hotta, Hajime Asahina, Masanori Kawakami, Ichiro Nakachi, Yukihiro Hasegawa, Kohei Okafuji, Aya Suzuki, Akihiko Miyanaga, Noriaki Sunaga, Hiromi Nagashima, Naoya Ikeda, Satoshi Watanabe, Yoshiaki Nagai, Megumi Furuta, Hidenori Kage, Daisuke Arai, Tatsuro Fukuhara, Masayuki Nakayama, Satoshi Morita, Kunihiko Kobayashi, Koichi Hagiwara
Detection of multiple druggable mutations of lung cancer from cytology specimens by MINtS: An advanced medicine a trial. Cancer science (2023)
Hirokazu Iso, Akihiko Miyanaga, Naohiro Kadoma, Kaoruko Shinbu, Takehiro Tozuka, Akari Murata, Shunichi Nishima, Yozo Sato, Shinji Nakamichi, Masaru Matsumoto, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike
Remarkable Clinical Response of ALK -Rearranged/ TP53 -Mutant Lung Adenocarcinoma with Liver Metastasis to Atezolizumab-Bevacizumab-Carboplatin-Paclitaxel After ALK Inhibitors: A Case Report. OncoTargets and therapy 16 (2023)
Kazuhito Misawa, Shinji Nakamichi, Hiroki Iida, Atsuhiro Nagano, Erika Mikami, Takehiro Tozuka, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Kaoru Kubota, Hiroki Yamaguchi, Masahiro Seike
Alectinib-Induced Severe Hemolytic Anemia in a Patient with ALK-Positive Non-Small Cell Lung Cancer: A Case Report. OncoTargets and therapy 16 (2023)
Anna Hayashi, Shinji Nakamichi, Yukako Nakayama, Atsuhiro Nagano, Erika Mikami, Natsuki Takano, Takehiro Tozuka, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Yasuhiro Terasaki, Kaoru Kubota, Masahiro Seike, Akihiko Gemma
Successful Treatment with Short-Term Steroid Against Severe Hepatitis Confirmed by Liver Biopsy in a Patient with Advanced Squamous-Cell Lung Cancer Receiving a Combination of Pembrolizumab, Carboplatin, and Nab-Paclitaxel: A Case Report. OncoTargets and therapy 15 (2022)
Masamitsu Shimizu, Akihiko Miyanaga, Masahiro Seike, Kuniko Matsuda, Masaru Matsumoto, Rintaro Noro, Kazue Fujita, Yoko Mano, Nobuhiko Furuya, Kaoru Kubota, Akihiko Gemma
The respiratory microbiome associated with chronic obstructive pulmonary disease comorbidity in non-small cell lung cancer. Thoracic cancer 13 (13) (2022)
Miwako Omori, Rintaro Noro, Masahiro Seike, Kuniko Matsuda, Mariko Hirao, Aya Fukuizumi, Natsuki Takano, Akihiko Miyanaga, Akihiko Gemma
Inhibitors of ABCB1 and ABCG2 overcame resistance to topoisomerase inhibitors in small cell lung cancer. Thoracic cancer 13 (15) (2022)
Yuki Kato, Yasuhiro Kato, Yuji Minegishi, Takahiro Suzuki, Shinji Nakamichi, Masaru Matsumoto, Akihiko Miyanaga, Rintaro Noro, Kaoru Kubota, Yasuhiro Terasaki, Masahiro Seike, Akihiko Gemma
Efficacy with Trastuzumab Deruxtecan for Non-Small-Cell Lung Cancer Harboring HER2 Exon 20 Insertion Mutation in a Patient with a Poor Performance Status: A Case Report. OncoTargets and therapy 14 (2021)